1. Korean Rehabilitaion Medicine Rehabilitation medicine of Korean Medicine. 4th ed. Seoul: Koonja Publishing Co. 2015:122–6.
2. Suh CH. Fibromyalgia. Korean J med. 2003;64(3):330–2.
3. Lee JY, Kim MS, Yum SL, Kyun YD. The Clinical Study on a Case of Fibromyalgia Syndrome Patient by Korean Medicine Treatment. JORM. 2016;26(4):127–36.
4. Lee CH, Lee MJ. Two Case Report on the Patient with Fibromyalgia Syndrome(FMS) with Chuna and Acupuncture. The Journal of Korea CHUNA Manual Medicine for Spine & Nerves. 2006;1(1):91–103.
5. Korean society of CHUNA Manual Medicine for Spine & Nerves. Chuna manual medicine. 1st ed. Seoul: Korean society of CHUNA Manual Medicine for Spine & Nerves. 2011:1558–9, 171–3, 182–3.
6. Braun M, Schwickert M, Nielsen A, et al. Effectiveness of Traditional Chinese “Gua Sha” Therapy in Patients with Chronic Neck Pain: A Randomized Controlled Trial. Pain Med. 2011;12(3):362–9.
8. Wolfe F, Clauw DJ, Fitzcharles MA, et al. The American College of Rheumatology Preliminary Diagnostic Criteria for Fibromyalgia and Measurement of Symptom Severity. Arthritis Care Res. 2010;62(5):600–10.
9. Bennett R. The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses. Clin Exp Rheumatol. 2005;23(5):154.
10. Lee JY, Park SH, Han SY, Park JY, Lee HJ. A Case-control Study of The Effect of Cotreatment with Sinseon Moxibustion on Low Back Pain of HIVD Patients. The Acupunt. 2011;28(4):77–83.
11. Offenbaecher M, Bondy B, de Jonge S, et al. Possible association of fibromyalgia with a polymorphism in the serotonin transporter gene regulatory region. Arthritis Rheum. 1999;42(11):2482–8.
12. Clauw DJ, Chrousos GP. Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenic mechanisms. Neuroimmunomodulation. 1997;4(3):134–53.
13. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990;33(2):160–72.
14. Lee SS. Diagnosis and Treatment of Fibromyalgia Syndrome. Korean J Med. 2013;84(5):650–8.
15. Salinsky M, Storzbach D, Munoz S. Cognitive effects of pregabalin in healthy volunteers A double-blind, placebo-controlled trial. Neurology. 2010;74(9):755–61.
16. Mease PJ, Clauw DJ, Gendreau RM, et al. The efficacy and safety of milnacipran for treatment of fibromyalgia. A randomized, double-blind, placebo-controlled trial. J Rheumatol. 2009;36(2):398–409.
17. Arnold LM, Russell IJ, Diri EW, et al. A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia. J Pain. 2008;9(9):792–805.
18. Schmidt-Wilcke T, Clauw DJ. Pharmacotherapy in fibromyalgia (FM)–implications for the underlying pathophysiology. Pharmacol Ther. 2010;127(3):283–94.
19. Häuser W, Klose P, Langhorst J, et al. Efficacy of different types of aerobic exercise in fibromyalgia syndrome: a systematic review and meta-analysis of randomised controlled trials. Arthritis Res Ther. 2010;12(3):79.
21. Bernardy K, Füber N, Köllner V, Häuser W. Efficacy of cognitive-behavioral therapies in fibromyalgia syndrome-a systematic review and metaanalysis of randomized controlled trials. J Rheumatol. 2010;37(10):1991–2005.
22. Gehlsen GM, Ganion LR, Helfst R. Fibroblast responses to variation in soft tissue mobilization pressure. Med Sci Sports Exerc. 1999;31(4):531–5.
23. Vardiman JP, Siedlik J, Herda T, et al. Instrument-assisted soft tissue mobilization: effects on the properties of human plantar flexors. Int J Sports Med. 2015;36(3):197–203.
24. Moon TW, Choi TY, Park TY, Lee MS. Chuna therapy for musculoskeletal pain: A systematic review of randomized clinical trials in Korean literature. Chin J Integr Med. 2013;19(3):228–32.